Pelthos Therapeutics PTHS
NYSE PTHS
$20.45 +0.19 (+0.94%)
As of: Oct 20, 2026 · 3:52 PM EDT

Pelthos Therapeutics (PTHS) EBT Margin (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported EBT Margin of -150.08% for Q2 2026, up 79.82 percentage points from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) EBT Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Pelthos Therapeutics' EBT Margin came in at -216.56%; for FY2025, it came in at -301.91%.

  • Per Business Quant data, the three quarters before Q2 2026 came in at -229.90% (Q1 2026), -304.46% (Q4 2025) and -225.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 26.66%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 25.18%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 18.19%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -131.41%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -4.34%
10 Pelthos Therapeutics 72.38 Mn -16.01 Mn 11.99 Mn -150.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -150.08%
Mar 31, 2026 -229.90%
Dec 31, 2025 -304.46%
Sep 30, 2025 -225.53%
API Access

Pelthos Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=PTHS&period=max&api_key=YOUR_API_KEY